Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions

Abstract

Helicobacter pylori (H. pylori) was reported to be associated with gastric carcinogenesis. Resistin-like molecule beta (RELMβ), a recently described goblet cell-specific protein, was demonstrated to aberrantly express in gastric cancer and correlated with its clinicopathological features. This study aimed to examine the association between H. pylori and RELMβ expression in gastric carcinoma and precursor lesions. H. pylori infection and RELMβ expression were immunohistochemically evaluated in gastric biopsies from 230 patients. The biopsies consisted of normal gastric mucosa (n=20), mucosa with chronic gastritis (n=41), intestinal metaplasia (n=42), dysplasia (n=31), intestinal-type adenocarcinoma (n=56), and diffuse-type adenocarcinoma (n=40). RELMβ expression was measured in gastric biopsies after H. pylori eradication therapy in a subgroup of 32 patients. Cultured gastric cancer cell line SGC-7901 was infected with H. pylori strains, and RELMβ expression was detected by reverse transcription PCR, real-time PCR and Western blotting. Higher RELMβ immunoreactivity was observed in H. pylori-positive intestinal metaplasia (P=0.003), dysplasia (P=0.032), intestinal-type (P=0.037) and diffuse-type adenocarcinomas (P=0.001) than in H. pylori-negative specimens. Expression rates of RELMβ in dysplasia (P=0.005), intestinal-type adenocarcinoma (P<0.001), and diffuse-type adenocarcinoma (P=0.001) were significantly correlated with the grade of H. pylori density. In addition, H. pylori eradication reduced the RELMβ intensity in intestinal metaplasia (P=0.001). Infection of gastric cancer SGC-7901 cells with cag pathogenicity island (PAI)-positive H. pylori TN2, but not with its PAI totally deleted mutant (TN2-ΔPAI) for 4–8 h, resulted in enhanced protein and transcript levels of RELMβ (P<0.05). In summary, our study suggested that H. pylori infection facilitated the expression of RELMβ in gastric garcinoma and precursor lesions.

Keywords

resistin-like molecule beta / Helicobacter pylori / gastric carcinoma / immunohistochemistry

References

[1] ShahMA, KelsenDP. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw, 2010, 8(4): 437-447

[2] CorreaP. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 1992, 52(24): 6735-6740

[3] HopkinsRJ, GirardiLS, TurneyEA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology, 1996, 110(4): 1244-1252

[4] LeeYC, ChiangTH, ChouCK, et al.. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology, 2016, 150(5): 1113-1124

[5] FujiokaT, HondaS, TokiedaM. Helicobacter pylori infection and gastric carcinoma in animal models. J Gastroenterol Hepatol, 2000, 15: 55-59 Suppl)

[6] LaurenP. The Two Histological Main Types Of Gastric Carcinoma: Diffuse And So-Called Intestinal-Type Carcinoma. Acta Pathol Microbiol Scand, 1965, 64(1): 31-49

[7] CorreaP, ShiaoYH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res, 1994, 54: 1941s-1943s(7 Supplement)

[8] SteppanCM, BrownEJ, WrightCM, et al.. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA, 2001, 98(2): 502-506

[9] HeW, WangML, JiangHQ, et al.. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology, 2003, 125(5): 1388-1397

[10] ShojimaN, OgiharaT, InukaiK, et al.. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia, 2005, 48(5): 984-992

[11] ArtisD, WangML, KeilbaughSA, et al.. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci USA, 2004, 101(37): 13 596-13 600

[12] PropheterDC, CharaAL, HarrisTA, et al.. Resistin-like molecule β is a bactericidal protein that promotes spatial segregation of the microbiota and the colonic epithelium. Proc Natl Acad Sci USA, 2017, 114(42): 11 027-11 033

[13] ZhengLD, TongQS, WengMX, et al.. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci, 2009, 54(2): 274-281

[14] ZhengL, TongQ, WengM, et al.. Expression of resistin-like molecule beta in Barrett’s esophagus: a novel biomarker for metaplastic epithelium. Dig Dis Sci, 2010, 55(1): 32-39

[15] ZhengL, WengM, HeJ, et al.. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virchows Arch, 2010, 456(1): 53-63

[16] LiD, BautistaMC, JiangSF, et al.. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol, 2016, 111(8): 1104-1113

[17] DixonMF, GentaRM, YardleyJH, et al.. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol, 1996, 20(10): 1161-1181

[18] IsomotoH, KawazoeK, InoueK, et al.. Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies. Dig Dis Sci, 2006, 51(12): 2302-2305

[19] NairMG, GuildKJ, DuY, et al.. Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J Immunol, 2008, 181(7): 4709-4715

[20] HoganSP, SeiduL, BlanchardC, et al.. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol, 2006, 118(1): 257-268

[21] MarshallBJ, WarrenJR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984, 1(8390): 1311-1315

[22] KuipersEJ, Perez-PerezGI, MeuwissenSG, et al.. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst, 1995, 87(23): 1777-1780

[23] TakeS, MizunoM, IshikiK, et al.. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol, 2005, 100(5): 1037-1042

[24] UemuraN, OkamotoS, YamamotoS, et al.. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 2001, 345(11): 784-789

[25] CorreaP. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol, 1988, 83(5): 504-509

[26] HazellSL, LeeA, BradyL, et al.. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis, 1986, 153(4): 658-663

[27] MarshallBJ, BarrettLJ, PrakashC, et al.. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology, 1990, 99(3): 697-702

[28] HazellSL, EvansDJ, GrahamDYJr.. Helicobacter pylori catalase. J Gen Microbiol, 1991, 137(1): 57-61

[29] CrabtreeJE, ShallcrossTM, HeatleyRV, et al.. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 1991, 32(12): 1473-1477

[30] Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum, 1994,61:1–241

[31] WangRQ, FangDC. Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues. J Gastroenterol Hepatol, 2006, 21(2): 425-431

[32] ZhengLD, YangCL, QiT, et al.. Effects of resistin-like molecule beta over-expression on gastric cancer cells in vitro. World J Gastroenterol, 2012, 18(8): 754-766

[33] ShabelnikMY, KostyukOV, MerentsevSV, et al.. Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2. Exp Oncol, 2009, 31(3): 134-139

[34] HatakeyamaM. The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol, 2006, 84(4): 301-308

[35] HatakeyamaM. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe, 2014, 15(3): 306-316